Avecho Biotechnology Limited (ASX:AVE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0040
-0.0010 (-20.00%)
Jul 25, 2025, 12:03 PM AEST

Avecho Biotechnology Revenue

In the year 2024, Avecho Biotechnology had annual revenue of 1.13M AUD with 139.19% growth. Avecho Biotechnology had revenue of 820.49K in the half year ending December 31, 2024, with 121.14% growth.

Revenue
1.13M
Revenue Growth
+139.19%
P/S Ratio
12.61
Revenue / Employee
75.51K
Employees
15
Market Cap
14.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.13M659.12K139.19%
Dec 31, 2023473.55K-655.71K-58.07%
Dec 31, 20221.13M335.66K42.30%
Dec 31, 2021793.60K408.97K106.33%
Dec 31, 2020384.63K-3.85M-90.92%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited24.61B
Pro Medicus184.58M
Cochlear2.31B
Sonic Healthcare9.33B
Ramsay Health Care17.12B
Telix Pharmaceuticals783.21M
Ansell3.00B
Mesoblast9.16M
Revenue Rankings